FMC (FMC) Expects Tariff Headwinds for Q1 as Q4 Earnings Slip

Group 1 - FMC Corp. reported Q4 2025 sales of $1.08 billion, a decrease of 11% year over year, with adjusted EBITDA of $280 million, down 17%, and adjusted EPS of $1.20, down 33% [1] - For 2026, FMC projects full-year sales between $3.6 billion and $3.8 billion, with adjusted EBITDA expected to be between $670 million and $730 million, while Q1 sales are anticipated to decline by around 5% and EBITDA by nearly 60% year over year due to one-off costs and tariff headwinds [3] - The company expects approximately $20 million in tariff-related headwinds in 2026, primarily impacting the first quarter [3] Group 2 - Moody's downgraded FMC's senior unsecured ratings to Ba1 from Baa3, resulting in junk status, and assigned a negative outlook due to challenges from patent expirations of its insect-control product Rynaxypyr in multiple countries [4] - FMC is an agricultural sciences company focused on crop protection, plant health, agriculture, pest control, and turf management, offering a range of products including insect control products, herbicides, insecticides, flutriafol-based fungicides, and bionematicides [5]